Details for 2020163565

Up to date per 02.04.2026

Actions

Title / Product Name

AUF CD47 GERICHTETE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020163565

EP Publication Number

3721888

E-Number

1505112

Language

PCT Number

Publication Date

14.10.2020 A

20.07.2022 B1

Registration Date

20.07.2022

AT Publication Date

15.08.2022

Application Date

05.02.2014

Registration Number

Priorities

05.02.2013

201361761133 P

IPC

A61K 38/17 20060101AFI20220204BHEP

Maximum Duration of Protection

05.02.2034

Owner

The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

The United States of America, as represented by the Secretary, Department of Health and Human Services6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20892-7660US

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA1111 Franklin Street, 12th Floor Oakland, CA 94607-5200US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

WEISKOPF, Kipp28 Stanton Road, Unit 5 Brookline, MA Massachusetts 02445US

HASENKRUG, Kim J.1990 Red Crow Road Victor, MT Montana 59875US

STODDART, Cheryl A.360 Esplanade Avenue Apt. 10 Pacifica, CA California 94044US

MCCUNE, Joseph M.904 Steiner Street San Francisco, CA California 94117US

WEISSMAN, Irving L.747 Santa Ynez Street Stanford, CA California 94305US

Information about Fees